Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer

Annals of Oncology

Volumn 18, Issue 6, 2007, Pages 1030-1036

  Kim, J G ^a   Sohn, S K ^a   Chae, Y S ^a   Cho, Y Y ^a   Bae, H I ^a   Yan, G ^a   Park, J Y ^a   Lee, M H ^a   Chung, H Y ^a   Yu, W ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

Gastric cancer; Gene; Polymorphism; Prognosis; VEGF

Indexed keywords

ADENINE; CYTOSINE; EPIRUBICIN; FLUOROURACIL; GENOMIC DNA; GUANINE; NIMUSTINE; PARAFFIN; THYMINE; VASCULOTROPIN; VASCULOTROPIN C;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA EXTRACTION; EMBEDDING; FEMALE; GASTRECTOMY; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH ADENOCARCINOMA; STOMACH CANCER; TREATMENT OUTCOME;

EID: 34447295882     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm085     Document Type: Article

References (34)

1. Kim JP, Hur YS, Choe KJ et al. Clinical analysis of 1136 early gastric cancers. Cancer Res Treat 1993; 25: 808-818.
2. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-543.
3. Yancopoule GD, Davis S, Gale NW et al. Vascular specific growth factors and blood vessel formation. Nature 2000; 407: 242-248.
4. Carmeliet P, Jain RK. Angiogenesis in cancer and other disease. Nature 2000; 407: 249-257.
5. Toi M, Matsumoto T, Bando H. Vascular endothelial growth factor: Its prognostic, predictive, and therapeutic implications. Lancet Oncol 2001: 2: 667-673.
6. Masuya D, Huang C-H, Liu D et al. The intratumoral expression of vascular endothelial growth factor and interleukin-8 asscociated with angiogenesis in nonsmall cell lung carcinoma patients. Cancer 2001; 92: 2628-2638.
7. Fontanini G, Faviana P, Lucchi M et al. A high vascular count and overexpression of vascular growth factor are associated with unfavorable prognosis in operated small cell lung cancer. Br J Cancer 2002: 86: 558-563.
8. Nishida N, Yano H, Komai K et al. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma. Cancer 2004; 101: 1364-1374.
9. Stacker SA, Achen MG, Jussila L et al. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002; 2: 573-583.
10. Ichikura I, Tomimatsu S, Ohkura L et al. Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric carcinoma. J Surg Oncol 2001; 78: 132-137.
11. Yonemura Y, Endo Y, Fujita H et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 1999; 5: 1823-1829.
12. Juttner S, Wissmann C, Jons T et al. Vascular endothelial growth factor-D and its receptor VEGFR-3: Two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol 2006; 24: 228-240.
13. Mattei MG, Borg JP, Rosnet O et al. Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively. Genomics 1996; 31: 168-169.
14. Tischer E, Mitchell R, Hartman T et al. The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266: 11947-11954.
15. Watson CJ, Webb NJA, Bottonley MJ, Brenchley PEC. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000; 12: 1230-1235.
16. Renner W, Kotschan S, Hoffman C et al. A common 936C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial factor plasma levels. J Vasc Res 2000; 37: 443-448.
17. Stevens A, Soden J, Brenchley PE et al. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 2003; 63: 812-816.
18. Howell WM, Bateman AC, Turner SJ et al. Influence of Vascular endothelial growth factor single nucleotide polymorphisms on tumor development in cutaneous malignant melanoma. Genes Immun 2002; 3: 229-232.
19. Lee SJ, Lee SY, Jeon HS et al. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 571-575.
20. Lin CC, Wu HC, Tsai FJ et al. Vascular endothelial growth factor gene 460C/T polymorphism is a biomarker for prostate cancer. Urology 2003; 62: 374-377.
21. Krippl P, Langsenlehner U, Renner W et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer. Int J Cancer 2003; 106: 468-471.
22. Ruzzo A, Giaziano I. Kawakami K et al. Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with with palliative chemotherapy. J Clin Oncol 2006; 24: 1883-1891.
23. Lu H, Shu X, Cui Y et al. Association of genetic polymorphisms in the VEGF gene with breast cancer survival. Cancer Res 2005; 65: 5015-5019.
24. Jin Q, Hemminki K, Enquist K et al. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 2005; 11: 3647-3653.
25. Dotor E, Cuatrecases M, Martinez-Iniesta M et al. Tumor thymidylate synthase 1496del6 genotype as a prognostic factor in colorectal cancer patients receivinq flourouracil based adjuvant treatment. J Clin Oncol 2006 24: 1603-1611.
26. Li D, Frazier M, Evans DB et al. Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. J Clin Oncol 2006; 24: 1720-1728.
27. Hamilton SR, Aaltonen LA. WHO Classification. Tumours of the Digestive System: Pathology & Genetics. Lyon, France IARC Press 2000.
28. Greene FL, Page DL, Fleming ID et al. The AJCC cancer staging manual, 6th edition. New York, NY: Springer-Verlag 2002.
29. Stephens M, Smith MJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
30. Gonzalez CA, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002; 100: 249-260.
31. Karayiannakis AJ, Syrigos KN, Polychronidis A et al. Circulating VEGF levels in the serum of gastric cancer patients. Ann Surg 2002; 236: 37-42.
32. Awata T, Inoue K, Kurihara S et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002; 51: 1630-1635.
33. Koukourakis MI, Papazoglou D, Giatromanolaki A et al. VEGF gene sequence variation defines VEGF gene expression status and angiagenic activity in non-small cell lung cancer. Lung Cancer 2004; 46: 293-298.
34. Hurwitz H, Fehrenbacher L, Novotny W et al. Bevacizumab plus innotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342.